Immunovia AB (publ) (STO:IMMNOV)
0.0371
+0.0042 (12.77%)
Nov 19, 2026, 1:54 PM CET
Immunovia AB Market Cap
Immunovia AB has a market cap or net worth of 24.96 million as of November 18, 2026. It is the 47,580th most valuable company in the world and the 744th biggest in Sweden. Its market cap has decreased by 86.51% in one year.
Market Cap
24.96M
Enterprise Value
8.26M
Revenue
1.95M
Global Rank
Country Rank
#744 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since December 1, 2015, Immunovia AB's market cap has decreased from 424.45M to 24.96M, a decrease of -94.12%. That is a compound annual growth rate of -22.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 24.96M | -83.66% |
| Dec 30, 2025 | 152.70M | 64.79% |
| Dec 30, 2024 | 92.66M | 15.47% |
| Dec 29, 2023 | 80.25M | -86.52% |
| Dec 30, 2022 | 595.21M | -64.93% |
| Dec 30, 2021 | 1.70B | -37.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 166.42B |
| Getinge AB | 77.08B |
| Sectra AB | 63.43B |
| Camurus AB | 44.39B |
| NextCell Pharma AB | 30.33M |
| ScandiDos AB | 29.79M |
| Orexo AB | 29.05M |
| Qlife Holding AB | 26.56M |